The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression

Overview of attention for article published in Clinical Cancer Research, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 11 X users
patent: 3 patents

googleplus: 1 Google+ user

Citations

dimensions_citation: 77 Dimensions

Readers on

mendeley: 80 Mendeley

Summary X Patents Google+ Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Cancer preventive or therapeutic agent, combined medicine, and screening method

Grant CN-115529818-B

China

Prophylactic or therapeutic agent for at least one cancer selected from the group…

Application CN-115529818-A

China

A prophylactic or therapeutic agent for at least one cancer selected from the group…

Application JP-7037160-B1

Japan

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.